BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37370134)

  • 21. PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer.
    Yin XK; Wang YL; Wang F; Feng WX; Bai SM; Zhao WW; Feng LL; Wei MB; Qin CL; Wang F; Chen ZL; Yi HJ; Huang Y; Xie PY; Kim T; Wang YN; Hou JW; Li CW; Liu Q; Fan XJ; Hung MC; Wan XB
    Oncogene; 2021 Feb; 40(7):1375-1389. PubMed ID: 33420374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA GHET1 promotes cervical cancer progression through regulating AKT/mTOR and Wnt/β-catenin signaling pathways.
    Liu Z; Luo S; Wu M; Huang C; Shi H; Song X
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31682716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.
    Kim SJ; Ju JS; Kang MH; Eun JW; Kim YH; Raninga PV; Khanna KK; Győrffy B; Pack CG; Han HD; Lee HJ; Gong G; Shin Y; Mills GB; Eyun SI; Park YY
    Theranostics; 2020; 10(18):7974-7992. PubMed ID: 32724453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Splicing Regulator p54
    Hu Z; Dong L; Li S; Li Z; Qiao Y; Li Y; Ding J; Chen Z; Wu Y; Wang Z; Huang S; Gao Q; Zhao Y; He X
    Hepatology; 2020 Aug; 72(2):548-568. PubMed ID: 31815296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
    Cai K; Jiang L; Wang J; Zhang H; Wang X; Cheng D; Dou J
    J Cancer Res Ther; 2014; 10(4):1063-70. PubMed ID: 25579555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulated IQUB promotes cell proliferation and migration via activating Akt/GSK3β/β-catenin signaling pathway in breast cancer.
    Li K; Ma YB; Zhang Z; Tian YH; Xu XL; He YQ; Xu L; Gao Y; Pan WT; Song WJ; He X; Wei L
    Cancer Med; 2018 Aug; 7(8):3875-3888. PubMed ID: 29968965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
    Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
    J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/β-catenin signaling.
    Tao C; Luo J; Tang J; Zhou D; Feng S; Qiu Z; Putti TC; Xiang T; Tao Q; Li L; Ren G
    Clin Epigenetics; 2020 Nov; 12(1):173. PubMed ID: 33203470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.
    Ryo A; Nakamura M; Wulf G; Liou YC; Lu KP
    Nat Cell Biol; 2001 Sep; 3(9):793-801. PubMed ID: 11533658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
    Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
    Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells.
    Ge L; Wang H; Xu X; Zhou Z; He J; Peng W; Du F; Zhang Y; Gong A; Xu M
    J Cell Mol Med; 2020 Jan; 24(2):1969-1979. PubMed ID: 31851779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spermidine/spermine N1-acetyltransferase regulates cell growth and metastasis via AKT/β-catenin signaling pathways in hepatocellular and colorectal carcinoma cells.
    Wang C; Ruan P; Zhao Y; Li X; Wang J; Wu X; Liu T; Wang S; Hou J; Li W; Li Q; Li J; Dai F; Fang D; Wang C; Xie S
    Oncotarget; 2017 Jan; 8(1):1092-1109. PubMed ID: 27901475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention.
    Wang X; Han M; Wang S; Sun Y; Zhao W; Xue Z; Liang X; Huang B; Li G; Chen A; Li X; Wang J
    Theranostics; 2022; 12(12):5451-5469. PubMed ID: 35910786
    [No Abstract]   [Full Text] [Related]  

  • 37. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells.
    Kuang J; Li L; Guo L; Su Y; Wang Y; Xu Y; Wang X; Meng S; Lei L; Xu L; Shao G
    J Exp Clin Cancer Res; 2016 Jun; 35(1):88. PubMed ID: 27259701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-oncogenic Roles of HLXB9 Protein in Insulinoma Cells through Interaction with Nono Protein and Down-regulation of the c-Met Inhibitor Cblb (Casitas B-lineage Lymphoma b).
    Desai SS; Kharade SS; Parekh VI; Iyer S; Agarwal SK
    J Biol Chem; 2015 Oct; 290(42):25595-608. PubMed ID: 26342078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Never in mitosis gene A-related kinase-8 promotes proliferation, migration, invasion, and stemness of breast cancer cells via β-catenin signalling activation.
    Kang E; Kim HK; Lee HB; Han W
    Sci Rep; 2023 Apr; 13(1):6829. PubMed ID: 37100815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brazilein inhibits epithelial-mesenchymal transition (EMT) and programmed death ligand 1 (PD-L1) expression in breast cancer cells.
    Wudtiwai B; Kodchakorn K; Shwe TH; Pothacharoen P; Phitak T; Suninthaboonrana R; Kongtawelert P
    Int Immunopharmacol; 2023 May; 118():109988. PubMed ID: 36933493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.